Location History:
- Boston, MA (US) (1995)
- Hayward, CA (US) (1996)
Company Filing History:
Years Active: 1995-1996
Title: Lucene Tong: Innovator in Medical Diagnostics
Introduction
Lucene Tong is a prominent inventor based in Boston, MA (US), known for his contributions to medical diagnostics through innovative technologies. With a total of 3 patents, he has made significant strides in the field of tissue analysis and diagnosis.
Latest Patents
One of his latest patents is a "Method for laser induced fluorescence of tissue." This method utilizes laser radiation to illuminate and induce fluorescence in tissue, allowing for the determination of its chemical composition or pathological conditions. The technology enables the laser radiation and the retrieved fluorescing radiation to be conveyed through a catheter using an array of optical fibers. The fluorescence spectrum can then be displayed and analyzed to provide valuable information regarding the tissue's condition within the human body.
Another notable patent is for the "Spectral diagnosis of diseased tissue." This invention relates to a method and apparatus designed for diagnosing gastrointestinal tissue conditions. The method excites fluorophores within the tissue using a laser, causing them to emit fluorescent radiation. By detecting this emitted radiation and comparing it to a reference emission from normal tissue, the presence of abnormal tissue can be determined.
Career Highlights
Lucene Tong is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in medical diagnostics. His work has garnered attention for its potential to improve diagnostic accuracy and patient outcomes.
Collaborations
Some of his notable coworkers include Michael S Feld and Rebecca Rae Richards-Kortum, who have contributed to his research endeavors.
Conclusion
Lucene Tong's innovative work in medical diagnostics exemplifies the impact of technology on healthcare. His patents reflect a commitment to enhancing diagnostic methods, ultimately benefiting patients and the medical community.